Parvin Tajik

Generating author description...

All published works

Action	Title	Year	Authors
+	Supplementary Table 2 from Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification	2023	Parvin Tajik Aleiko H. Zwinderman Ben W. Mol Patrick M. Bossuyt
+	Supplementary Table 1 from Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification	2023	Parvin Tajik Aleiko H. Zwinderman Ben W. Mol Patrick M. Bossuyt
+	Supplementary Table 1 from Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification	2023	Parvin Tajik Aleiko H. Zwinderman Ben W. Mol Patrick M. Bossuyt
+	Supplementary Table 2 from Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification	2023	Parvin Tajik Aleiko H. Zwinderman Ben W. Mol Patrick M. Bossuyt
+	Data from Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification	2023	Parvin Tajik Aleiko H. Zwinderman Ben W. Mol Patrick M. Bossuyt
+	Data from Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification	2023	Parvin Tajik Aleiko H. Zwinderman Ben W. Mol Patrick M. Bossuyt
+ PDF Chat	Evaluation of biomarkers for treatment selection using individual participant data from multiple clinical trials	2018	Chaeryon Kang Holly Janes Parvin Tajik Henk Groen Ben W. Mol Corine M. Koopmans Kim Broekhuijsen Eva F. Zwertbroek Maria G. van Pampus Maureen Franssen
+	Evaluating Biomarkers for Guiding Treatment Decisions.	2015	Patrick M. Bossuyt Parvin Tajik
+	Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification	2013	Parvin Tajik Aleiko H. Zwinderman Ben W. Mol Patrick M. Bossuyt
+ PDF Chat	SYNTAX score II	2013	Parvin Tajik Katrien Oude Rengerink Ben W. Mol Patrick M. Bossuyt

Common Coauthors

Coauthor	Papers Together
Ben W. Mol	9
Patrick M. Bossuyt	9
Aleiko H. Zwinderman	7
Maria G. van Pampus	1
Katrien Oude Rengerink	1
Eva F. Zwertbroek	1
Chaeryon Kang	1
Corine M. Koopmans	1
Henk Groen	1
Maureen Franssen	1
Holly Janes	1
Kim Broekhuijsen	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials	2005	Daniel J. Sargent Barbara A. Conley Carmen J. Allegra Laurence Collette	4
+ PDF Chat	The Use of Genomics in Clinical Trial Design	2008	Richard Simon	3
+ PDF Chat	Genomic advances and their impact on clinical trial design	2009	Sumithra J. Mandrekar Daniel J. Sargent	3
+	Biomarkers and surrogate end points—the challenge of statistical validation	2010	Marc Buyse Daniel J. Sargent Axel Grothey Alastair Matheson Aimery de Gramont	3
+ PDF Chat	Randomized Phase III Clinical Trial Designs for Targeted Agents	2008	Antje Hoering Mike LeBlanc John J. Crowley	3
+	Advances in clinical trial designs for predictive biomarker discovery and validation	2009	Richard Simon	3
+ PDF Chat	Statistical design of personalized medicine interventions: The Clarification of Optimal Anticoagulation through Genetics (COAG) trial	2010	Benjamin French Jungnam Joo Nancy L. Geller Stephen E. Kimmel Yves Rosenberg Jeffrey L. Anderson Brian F. Gage Julie A. Johnson Jonas H. Ellenberg	3
+ PDF Chat	Biomarker-Adaptive Threshold Design: A Procedure for Evaluating Treatment With Possible Biomarker-Defined Subset Effect	2007	Wei Jiang Boris Freidlin Richard H. Simon	3
+ PDF Chat	A threshold sample-enrichment approach in a clinical trial with heterogeneous subpopulations	2010	Aiyi Liu Chunling Liu Qizhai Li Kai Yu Vivian W.S. Yuan	3
+	Inference on treatment effects for targeted clinical trials under enrichment design	2009	Jen‐pei Liu Jr‐Rung Lin Shein‐Chung Chow	3
+ PDF Chat	Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine	2008	Xian Zhou Suyu Liu Edward S. Kim Roy S. Herbst J. Jack Lee	3
+ PDF Chat	Clinical Trial Designs for Evaluating the Medical Utility of Prognostic and Predictive Biomarkers in Oncology	2009	Richard Simon	3
+	An adaptive Simon Two-Stage Design for Phase 2 studies of targeted therapies	2007	Cheryl L. Jones Eric Holmgren	3
+ PDF Chat	The Cross-Validated Adaptive Signature Design	2010	Boris Freidlin Wenyu Jiang Richard Simon	3
+ PDF Chat	A Bayesian adaptive design with biomarkers for targeted therapies	2010	Jens C. Eickhoff KyungMann Kim Jason Beach Jill Kolesar Jason Gee	3
+ PDF Chat	Adaptive Signature Design: An Adaptive Clinical Trial Design for Generating and Prospectively Testing A Gene Expression Signature for Sensitive Patients	2005	Boris Freidlin Richard Simon	3
+	Trial design for evaluation of novel targeted therapies	2009	John Farley Peter G. Rose	3
+	Designs and adaptive analysis plans for pivotal clinical trials of therapeutics and companion diagnostics	2008	Richard Simon	3
+ PDF Chat	Measuring the Performance of Markers for Guiding Treatment Decisions	2011	Holly Janes Margaret S. Pepe Patrick M. Bossuyt William E. Barlow	3
+	Towards validation of statistically reliable biomarkers	2007	Marc Buyse	3
+ PDF Chat	Development and validation of biomarker classifiers for treatment selection	2007	Richard Simon	3
+ PDF Chat	Predictive biomarker validation in practice: lessons from real trials	2010	Sumithra J. Mandrekar Daniel J. Sargent	3
+ PDF Chat	Evaluating Markers for Selecting a Patient's Treatment	2004	Xiao Song Margaret S. Pepe	3
+	Molecular biomarkers to individualise treatment: assessing the evidence	2009	Chee Khoon Lee Sarah J. Lord Alan S. Coates R. John Simes	3
+	Biomarkers and the design of clinical trials in cancer	2007	Graeme Fraser Ralph M. Meyer	3
+	Biomarker-adaptive clinical trial designs	2010	Boris Freidlin Edward L. Korn	3
+	Clinical trial methods to discover and validate predictive markers for treatment response in cancer	2003	Soonmyung Paik	3
+ PDF Chat	An Approach to Evaluating and Comparing Biomarkers for Patient Treatment Selection	2014	Holly Janes Marshall Brown Ying Huang Margaret S. Pepe	2
+	Clinical Trials of Novel and Targeted Therapies: Endpoints, Trial Design, and Analysis	2007	Vera J. Suman Amylou C. Dueck Daniel J. Sargent	2
+ PDF Chat	Assessing Treatment‐Selection Markers using a Potential Outcomes Framework	2012	Ying Huang Peter B. Gilbert Holly Janes	2
+	Estimation of Regression Coefficients When Some Regressors are not Always Observed	1994	James M. Robins Andrea Rotnitzky Lue Ping Zhao	1
+	Practical perspectives of personalized healthcare in oncology	2012	Darren Hodgson Robert Wellings Christopher Harbron	1
+	Assessing heterogeneity of treatment effect in a clinical trial with the proportional interactions model	2013	Stephanie Kovalchik Ravi Varadhan Carlos O. Weiss	1
+ PDF Chat	Designing a study to evaluate the benefit of a biomarker for selecting patient treatment	2015	Holly Janes Marshall Brown Margaret S. Pepe	1
+	The Threshold Approach to Clinical Decision Making	1980	Stephen G. Pauker Jerome P. Kassirer	1
+	Multivariate binary discrimination by the kernel method	1976	J. Aitchison Colin Aitken	1
+	From biomarkers to medical tests: The changing landscape of test evaluation	2013	Andrea R. Horvath Sarah J. Lord Andrew St John Sverre Sandberg Christa M. Cobbaert Stefan Lorenz Phillip Monaghan Wilma D.J. Verhagen-Kamerbeek Christoph Ebert Patrick M. Bossuyt	1
+	Clinical trial designs for targeted agents	2002	Brigette Ma Carolyn D. Britten Lillian L. Siu	1
+	Clinical Trial Designs for Prospective Validation of Biomarkers	2005	Sumithra J. Mandrekar Axel Grothey Matthew P. Goetz Daniel J. Sargent	1
+ PDF Chat	Variable Selection for Qualitative Interactions in Personalized Medicine While Controlling the Family-Wise Error Rate	2011	Lacey Gunter Ji Zhu Susan A. Murphy	1
+ PDF Chat	Discussion of combining biomarkers to optimize patient treatment recommendations	2014	Ying‐Qi Zhao Michael R. Kosorok	1
+ PDF Chat	Estimating optimal treatment regimes from a classification perspective	2012	Baqun Zhang Anastasios A. Tsiatis Marie Davidian Min Zhang Eric B. Laber	1
+ PDF Chat	All-Comers versus Enrichment Design Strategy in Phase II Trials	2011	Sumithra J. Mandrekar Daniel J. Sargent	1
+	A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis	2002	Paul C. Lambert Alex J. Sutton Keith R. Abrams David R. Jones	1
+	NHLBI clinical trials workshop: an executive summary	2012	Gang Zheng Colin O. Wu Song Yang Myron A. Waclawiw David L. DeMets Nancy L. Geller	1
+	The efficiency of clinical trial designs for predictive biomarker validation	2010	KY Young Amy Laird Xiao‐Hua Zhou	1
+	A Multivariate Test of Interaction for Use in Clinical Trials	1999	Dean Follmann Michael A. Proschan	1
+	A capture-recapture analysis demonstrated that randomized controlled trials evaluating the impact of diagnostic tests on patient outcomes are rare	2011	Lavinia Ferrante di Ruffano Clare Davenport Anne Eisinga Chris Hyde Jonathan J Deeks	1
+	A class of smooth estimators for discrete distributions	1981	Min-Chiang Wang John Van Ryzin	1
+	Integrating predictive biomarkers and classifiers into oncology clinical development programmes	2011	Robert A. Beckman Jason Clark Cong Chen	1